In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...

State must walk a fine line between playing the green card in Washington and standing tall alongside EU colleagues ...

JPMorgan is sticking with Eli Lilly (LLY) as its top biopharma pick for 2025, while also highlighting Gilead Sciences (GILD) ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous value they offer.

John Hancock Multifactor Large Cap ETF uses a multifactor strategy but lags in returns. Learn why JHML underperforms compared ...

There's no doubt that the world's second-most valuable stock is important. But the AI harbinger has taken on a different role ...

PepsiCo (PEP) is a 'Strong Buy' with robust profitability, strategic growth, and decade-low valuation. Read an investment ...

Amid a looming trade war with the U.S. that could see import tariffs on both sides of the border, Loblaw has been ...

In 2025, church members are visible across all aspects of sports — as athletes, coaches, owners and executives.

In this excellent study, science journalist Hall (Wisdom) surveys the distinctive biology and behavior of snakes. He ...

Mehmet Oz, Trump's nominee to lead the Centers for Medicare and Medicaid Services, pledged to divest his investments in hospitals and insurers if confirmed to lead the agency, he said in a filing with ...